![Sath Nirmalananthan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 61 364 $ au 31/05/2026
Sath Nirmalananthan is currently a Non-Executive Director at The Institute of Cancer Research: Royal Cancer Hospital and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Chief Financial Officer, Secretary & Director at Scancell Holdings Plc from 2024 to 2026, Research Analyst at Nomura International Plc from 2012 to 2013, CFO-Europe, Middle East & Africa at Prenetics Ltd., and Head-Auditor at KPMG UK Ltd. Education includes an undergraduate degree from King's College London.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2025 | 190 476 ( 0,02% ) | 61 364 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
The Institute of Cancer Research: Royal Cancer Hospital
 The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SCANCELL HOLDINGS PLC | Directeur Financier/CFO | 24/04/2026 |
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2013 |
KPMG UK Ltd.
 KPMG UK Ltd. Investment ManagersFinance Provides financial advisory services | Comptroller/Controller/Auditor | - |
Prenetics Ltd.
 Prenetics Ltd. Medical/Nursing ServicesHealth Services Provides genetic testing and digital healthcare information services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Nomura International Plc
Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Institute of Cancer Research: Royal Cancer Hospital
The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Commercial Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
KPMG UK Ltd.
KPMG UK Ltd. Investment ManagersFinance Provides financial advisory services | Finance |
Prenetics Ltd.
Prenetics Ltd. Medical/Nursing ServicesHealth Services Provides genetic testing and digital healthcare information services | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
